FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer

by Amiri-Kordestani, L., Beaver, J.A, Bloomquist, E., Ghosh, S., Kalavar, S., Mixter, B.D, Mulkey, F., Osgood, C., Pazdur, R., Philip, R., Pierce, W.F, Rizvi, F., Roy, A., Royce, M., Tang, S.
Published 2022

Corrigendum to “Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria”: [Annals of Oncology 32 (2021) 950-953]...

by Amiri-Kordestani, L., Beaver, J.A, Bhatnagar, V., Bloomquist, E., Booth, B., Cardoso, F., Fashoyin-Aje, L., Gao, J.J, Goetz, M.P, Hodgdon, C., Hurvitz, S.A, Ison, G., Krol, D., Mauro, L., Miller, C.P, Narayan, P., Osgood, C., Pazdur, R., Regan, M.M
Published 2022